GML
IBB icon

Gems Management Ltd’s iShares Biotechnology ETF IBB Stock Holding History

Gems Management Ltd’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$471K Sell
6,747
-5,100
-43% -$334K 0.67% 28
2013
Q2 		$687K Buy
+11,847
New +$685K 1.69% 29

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Gems Management Ltd's IBB Position: Q3 2013 in Review

Gems Management Ltd reduced its iShares Biotechnology ETF (IBB) stake by 43% in Q3 2013, selling an estimated $334K and leaving 6,747 shares worth $471K. The position accounts for 0.67% of the portfolio, ranked #28.

Gems Management Ltd first reported a position in IBB in Q2 2013 and has held it in 2 quarters since. The position peaked at $687K in Q2 2013. 253 funds tracked by Wall St. Rank hold IBB as of Q3 2013.

  • Gems Management Ltd held 6,747 shares of iShares Biotechnology ETF worth $471K as of Q3 2013.
  • Gems Management Ltd sold 5,100 iShares Biotechnology ETF shares in Q3 2013, an estimated $334K.
  • iShares Biotechnology ETF made up 0.67% of Gems Management Ltd's portfolio in Q3 2013, its #28 holding.
  • Gems Management Ltd first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 2 quarters since.
  • Gems Management Ltd's iShares Biotechnology ETF position peaked at $687K in Q2 2013.
  • 253 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2013.

Based on Gems Management Ltd's 13F filing for Q3 2013, filed 4 Nov 2013.